Taufiek Konrad Rajab
Concepts (497)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 48 | 2026 | 327 | 21.990 |
Why?
| | Heart Valve Prosthesis | 12 | 2025 | 89 | 6.570 |
Why?
| | Heart Valve Prosthesis Implantation | 12 | 2025 | 103 | 5.890 |
Why?
| | Tissue Adhesions | 25 | 2021 | 37 | 5.190 |
Why?
| | Aortic Valve | 16 | 2025 | 130 | 4.610 |
Why?
| | Pulmonary Valve | 8 | 2026 | 61 | 4.470 |
Why?
| | Heart Valves | 10 | 2025 | 31 | 4.160 |
Why?
| | Cardiac Surgical Procedures | 11 | 2025 | 331 | 4.110 |
Why?
| | Tissue Donors | 16 | 2026 | 130 | 4.010 |
Why?
| | Lung Transplantation | 10 | 2022 | 39 | 4.000 |
Why?
| | Heart Defects, Congenital | 12 | 2025 | 625 | 3.790 |
Why?
| | Tissue and Organ Procurement | 9 | 2026 | 52 | 3.120 |
Why?
| | Heart Valve Diseases | 8 | 2025 | 55 | 3.100 |
Why?
| | Organ Preservation | 4 | 2026 | 34 | 3.090 |
Why?
| | Cryopreservation | 3 | 2026 | 41 | 2.560 |
Why?
| | Humans | 123 | 2026 | 53246 | 2.460 |
Why?
| | Bioprosthesis | 5 | 2025 | 41 | 2.380 |
Why?
| | Postoperative Complications | 14 | 2026 | 1099 | 2.300 |
Why?
| | Organ Transplantation | 5 | 2024 | 48 | 2.260 |
Why?
| | Models, Animal | 10 | 2026 | 233 | 2.230 |
Why?
| | Swine | 15 | 2026 | 440 | 2.040 |
Why?
| | Child | 26 | 2026 | 7384 | 1.920 |
Why?
| | Echocardiography | 8 | 2024 | 408 | 1.920 |
Why?
| | Animals | 49 | 2026 | 13528 | 1.900 |
Why?
| | Bioartificial Organs | 3 | 2020 | 3 | 1.870 |
Why?
| | Lung | 7 | 2022 | 481 | 1.770 |
Why?
| | Vitrification | 2 | 2026 | 5 | 1.770 |
Why?
| | Thrombosis | 3 | 2023 | 250 | 1.750 |
Why?
| | Extracorporeal Membrane Oxygenation | 4 | 2023 | 305 | 1.660 |
Why?
| | Peritoneal Diseases | 8 | 2013 | 15 | 1.630 |
Why?
| | Graft Rejection | 9 | 2024 | 166 | 1.630 |
Why?
| | Peritoneum | 8 | 2017 | 16 | 1.580 |
Why?
| | Immunosuppressive Agents | 3 | 2025 | 253 | 1.580 |
Why?
| | Truncus Arteriosus, Persistent | 2 | 2024 | 7 | 1.570 |
Why?
| | Transplantation, Heterologous | 5 | 2024 | 78 | 1.540 |
Why?
| | Transplants | 2 | 2023 | 19 | 1.530 |
Why?
| | Tissue Scaffolds | 5 | 2020 | 40 | 1.500 |
Why?
| | Biocompatible Materials | 7 | 2019 | 67 | 1.490 |
Why?
| | Tissue Engineering | 4 | 2020 | 74 | 1.430 |
Why?
| | Aortic Valve Stenosis | 3 | 2021 | 79 | 1.300 |
Why?
| | Norwood Procedures | 2 | 2021 | 61 | 1.270 |
Why?
| | Heart Neoplasms | 3 | 2019 | 31 | 1.230 |
Why?
| | Hypoplastic Left Heart Syndrome | 2 | 2021 | 97 | 1.220 |
Why?
| | Heart Failure | 8 | 2024 | 531 | 1.210 |
Why?
| | Suture Techniques | 4 | 2014 | 57 | 1.130 |
Why?
| | Thoracic Surgery | 3 | 2017 | 22 | 1.120 |
Why?
| | Death | 4 | 2026 | 23 | 1.100 |
Why?
| | Heart-Assist Devices | 4 | 2024 | 157 | 1.080 |
Why?
| | Disease Models, Animal | 12 | 2024 | 1517 | 1.080 |
Why?
| | Ischemia | 3 | 2014 | 158 | 1.060 |
Why?
| | Cryoprotective Agents | 2 | 2026 | 7 | 1.060 |
Why?
| | Transplantation, Homologous | 6 | 2023 | 154 | 1.060 |
Why?
| | Tacrolimus | 2 | 2025 | 61 | 1.040 |
Why?
| | Rats | 19 | 2024 | 3164 | 1.030 |
Why?
| | Aortic Valve Insufficiency | 3 | 2022 | 25 | 1.030 |
Why?
| | Heart Atria | 3 | 2023 | 63 | 1.000 |
Why?
| | Perfusion | 4 | 2022 | 49 | 0.990 |
Why?
| | Marfan Syndrome | 2 | 2024 | 26 | 0.980 |
Why?
| | Tourniquets | 2 | 2023 | 9 | 0.950 |
Why?
| | Forecasting | 3 | 2024 | 152 | 0.940 |
Why?
| | Infant, Newborn | 12 | 2024 | 2913 | 0.930 |
Why?
| | Cornea | 1 | 2026 | 54 | 0.920 |
Why?
| | Cell Separation | 1 | 2025 | 76 | 0.910 |
Why?
| | Rodentia | 2 | 2024 | 17 | 0.900 |
Why?
| | Postoperative Care | 1 | 2026 | 109 | 0.890 |
Why?
| | Internship and Residency | 5 | 2017 | 439 | 0.870 |
Why?
| | Treatment Outcome | 20 | 2024 | 5597 | 0.850 |
Why?
| | Adult | 28 | 2024 | 14541 | 0.840 |
Why?
| | Flow Cytometry | 1 | 2025 | 400 | 0.820 |
Why?
| | Out-of-Hospital Cardiac Arrest | 2 | 2021 | 28 | 0.810 |
Why?
| | Shock, Hemorrhagic | 2 | 2014 | 12 | 0.810 |
Why?
| | Pelvic Bones | 2 | 2014 | 13 | 0.810 |
Why?
| | Female | 44 | 2026 | 28792 | 0.800 |
Why?
| | Aortic Diseases | 2 | 2022 | 54 | 0.790 |
Why?
| | Coronary Vessel Anomalies | 1 | 2024 | 37 | 0.790 |
Why?
| | Vena Cava, Superior | 1 | 2023 | 21 | 0.780 |
Why?
| | Follow-Up Studies | 10 | 2023 | 2318 | 0.760 |
Why?
| | Hyaluronic Acid | 4 | 2017 | 39 | 0.760 |
Why?
| | Fractures, Bone | 2 | 2014 | 106 | 0.740 |
Why?
| | Coronary Artery Bypass | 4 | 2019 | 134 | 0.720 |
Why?
| | Rats, Wistar | 12 | 2017 | 192 | 0.690 |
Why?
| | Puerperal Disorders | 3 | 2018 | 22 | 0.680 |
Why?
| | Informed Consent | 2 | 2013 | 94 | 0.680 |
Why?
| | Heart Arrest | 1 | 2023 | 144 | 0.670 |
Why?
| | Biological Evolution | 1 | 2021 | 55 | 0.650 |
Why?
| | Airway Extubation | 1 | 2021 | 30 | 0.650 |
Why?
| | Coronary Aneurysm | 2 | 2010 | 18 | 0.640 |
Why?
| | Polymers | 1 | 2020 | 51 | 0.640 |
Why?
| | Infant | 9 | 2026 | 3808 | 0.620 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2021 | 136 | 0.610 |
Why?
| | Eisenmenger Complex | 1 | 2019 | 2 | 0.600 |
Why?
| | Heart-Lung Transplantation | 1 | 2019 | 2 | 0.600 |
Why?
| | Fontan Procedure | 1 | 2020 | 67 | 0.600 |
Why?
| | Dextrocardia | 1 | 2019 | 4 | 0.600 |
Why?
| | Paraganglioma | 1 | 2019 | 14 | 0.600 |
Why?
| | Fellowships and Scholarships | 2 | 2017 | 124 | 0.600 |
Why?
| | Tracheal Stenosis | 1 | 2019 | 14 | 0.590 |
Why?
| | Male | 29 | 2026 | 27444 | 0.590 |
Why?
| | Practice Guidelines as Topic | 2 | 2020 | 502 | 0.580 |
Why?
| | Evidence-Based Medicine | 1 | 2020 | 275 | 0.580 |
Why?
| | Heart Septal Defects, Atrial | 1 | 2019 | 45 | 0.580 |
Why?
| | Soybean Oil | 1 | 2018 | 4 | 0.570 |
Why?
| | Trachea | 1 | 2019 | 55 | 0.560 |
Why?
| | Surgical Procedures, Operative | 2 | 2010 | 66 | 0.560 |
Why?
| | Proctoscopy | 1 | 2018 | 2 | 0.560 |
Why?
| | Digital Rectal Examination | 1 | 2018 | 3 | 0.560 |
Why?
| | Phospholipids | 1 | 2018 | 59 | 0.550 |
Why?
| | Coronary Stenosis | 1 | 2019 | 99 | 0.540 |
Why?
| | Abnormalities, Multiple | 1 | 2019 | 166 | 0.530 |
Why?
| | Retrospective Studies | 15 | 2026 | 6821 | 0.530 |
Why?
| | Reperfusion Injury | 1 | 2018 | 83 | 0.520 |
Why?
| | Travel | 1 | 2017 | 37 | 0.510 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 177 | 0.510 |
Why?
| | Coronavirus Infections | 1 | 2020 | 188 | 0.500 |
Why?
| | Aorta | 3 | 2024 | 172 | 0.500 |
Why?
| | Percutaneous Coronary Intervention | 1 | 2020 | 329 | 0.490 |
Why?
| | Abdominal Wall | 3 | 2021 | 13 | 0.490 |
Why?
| | Education, Medical, Graduate | 2 | 2017 | 219 | 0.470 |
Why?
| | Oxygen | 1 | 2018 | 338 | 0.460 |
Why?
| | Pandemics | 1 | 2020 | 595 | 0.460 |
Why?
| | General Surgery | 2 | 2016 | 108 | 0.450 |
Why?
| | Cardiovascular Diseases | 1 | 2020 | 501 | 0.440 |
Why?
| | Laparoscopy | 4 | 2010 | 180 | 0.430 |
Why?
| | Anticoagulants | 3 | 2023 | 280 | 0.420 |
Why?
| | Surgical Instruments | 2 | 2015 | 29 | 0.420 |
Why?
| | Intraoperative Period | 1 | 2014 | 46 | 0.410 |
Why?
| | Lasers, Semiconductor | 1 | 2013 | 7 | 0.390 |
Why?
| | Hypotension | 1 | 2014 | 62 | 0.390 |
Why?
| | Femoral Artery | 1 | 2014 | 106 | 0.390 |
Why?
| | Hemodynamics | 4 | 2023 | 236 | 0.390 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 1 | 2013 | 7 | 0.390 |
Why?
| | Transplantation, Heterotopic | 2 | 2024 | 6 | 0.390 |
Why?
| | Coronary Angiography | 3 | 2024 | 369 | 0.380 |
Why?
| | Prosthesis Design | 3 | 2025 | 266 | 0.380 |
Why?
| | Middle Aged | 14 | 2024 | 13422 | 0.380 |
Why?
| | Transplantation, Autologous | 3 | 2020 | 488 | 0.380 |
Why?
| | Surgery, Computer-Assisted | 1 | 2013 | 54 | 0.370 |
Why?
| | Adolescent | 7 | 2026 | 6912 | 0.370 |
Why?
| | Pregnancy, Ectopic | 2 | 2009 | 7 | 0.370 |
Why?
| | Jejunum | 1 | 2012 | 55 | 0.370 |
Why?
| | Endoscopy | 1 | 2013 | 128 | 0.370 |
Why?
| | Polyesters | 2 | 2010 | 14 | 0.360 |
Why?
| | Prednisolone | 1 | 2012 | 56 | 0.360 |
Why?
| | Hyperglycemia | 1 | 2012 | 90 | 0.360 |
Why?
| | Electrocoagulation | 2 | 2009 | 12 | 0.360 |
Why?
| | Coronary Vessels | 2 | 2010 | 170 | 0.360 |
Why?
| | Abdominal Injuries | 2 | 2012 | 35 | 0.350 |
Why?
| | Tomography, X-Ray Computed | 5 | 2020 | 1183 | 0.350 |
Why?
| | Enteral Nutrition | 1 | 2012 | 157 | 0.350 |
Why?
| | Pericarditis, Constrictive | 1 | 2011 | 2 | 0.350 |
Why?
| | Biomedical Engineering | 3 | 2020 | 4 | 0.350 |
Why?
| | Pericardiectomy | 1 | 2011 | 6 | 0.350 |
Why?
| | Receptors, Tachykinin | 1 | 2011 | 3 | 0.350 |
Why?
| | Hernia, Umbilical | 1 | 2011 | 20 | 0.340 |
Why?
| | Glucose | 3 | 2012 | 361 | 0.340 |
Why?
| | Syphilis, Cardiovascular | 1 | 2011 | 2 | 0.340 |
Why?
| | Anti-Inflammatory Agents | 1 | 2012 | 164 | 0.330 |
Why?
| | Myxoma | 1 | 2011 | 17 | 0.330 |
Why?
| | Child, Preschool | 4 | 2026 | 4164 | 0.330 |
Why?
| | Kidney Transplantation | 1 | 2013 | 204 | 0.330 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2011 | 28 | 0.330 |
Why?
| | Angina Pectoris | 1 | 2010 | 20 | 0.330 |
Why?
| | Microsurgery | 1 | 2010 | 32 | 0.320 |
Why?
| | Anastomosis, Surgical | 1 | 2010 | 69 | 0.320 |
Why?
| | Aorta, Abdominal | 1 | 2010 | 39 | 0.320 |
Why?
| | Vena Cava, Inferior | 1 | 2010 | 62 | 0.310 |
Why?
| | Glucans | 2 | 2010 | 10 | 0.310 |
Why?
| | Waiting Lists | 3 | 2026 | 56 | 0.310 |
Why?
| | Incidence | 3 | 2023 | 1085 | 0.300 |
Why?
| | Bioengineering | 2 | 2020 | 3 | 0.300 |
Why?
| | RNA, Messenger | 3 | 2012 | 1133 | 0.300 |
Why?
| | Hemangioma | 1 | 2010 | 86 | 0.300 |
Why?
| | Consent Forms | 1 | 2009 | 7 | 0.290 |
Why?
| | United States | 10 | 2024 | 5413 | 0.290 |
Why?
| | Cautery | 1 | 2008 | 3 | 0.290 |
Why?
| | Ovary | 1 | 2009 | 103 | 0.290 |
Why?
| | Gels | 1 | 2008 | 22 | 0.280 |
Why?
| | Text Messaging | 1 | 2009 | 23 | 0.280 |
Why?
| | Blood Pressure | 3 | 2023 | 518 | 0.280 |
Why?
| | Sutures | 1 | 2008 | 36 | 0.280 |
Why?
| | Vascular Surgical Procedures | 1 | 2010 | 171 | 0.280 |
Why?
| | Reoperation | 2 | 2021 | 476 | 0.280 |
Why?
| | Tuberculosis, Spinal | 1 | 2008 | 4 | 0.280 |
Why?
| | Polyglutamic Acid | 1 | 2008 | 1 | 0.270 |
Why?
| | Cellulose, Oxidized | 1 | 2008 | 4 | 0.270 |
Why?
| | Graft Survival | 3 | 2026 | 158 | 0.270 |
Why?
| | Hydrogels | 1 | 2008 | 26 | 0.270 |
Why?
| | Low Back Pain | 1 | 2008 | 31 | 0.270 |
Why?
| | Pregnancy | 7 | 2023 | 2610 | 0.260 |
Why?
| | Skin, Artificial | 1 | 2007 | 11 | 0.260 |
Why?
| | Ontario | 2 | 2017 | 50 | 0.260 |
Why?
| | Gelatin | 1 | 2007 | 22 | 0.260 |
Why?
| | Uterine Diseases | 1 | 2007 | 10 | 0.260 |
Why?
| | Stents | 3 | 2020 | 376 | 0.260 |
Why?
| | Physician-Patient Relations | 1 | 2009 | 146 | 0.260 |
Why?
| | Skin Transplantation | 1 | 2007 | 43 | 0.260 |
Why?
| | Lumbar Vertebrae | 1 | 2008 | 101 | 0.260 |
Why?
| | Young Adult | 6 | 2024 | 4514 | 0.260 |
Why?
| | Patient Education as Topic | 1 | 2010 | 325 | 0.250 |
Why?
| | Patient Satisfaction | 1 | 2009 | 292 | 0.250 |
Why?
| | Pericardium | 2 | 2021 | 31 | 0.250 |
Why?
| | Heart Arrest, Induced | 2 | 2017 | 7 | 0.250 |
Why?
| | Radiography | 3 | 2013 | 476 | 0.240 |
Why?
| | Time Factors | 6 | 2025 | 2992 | 0.240 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2010 | 523 | 0.230 |
Why?
| | Materials Testing | 2 | 2020 | 55 | 0.230 |
Why?
| | Injections, Intramuscular | 1 | 2025 | 55 | 0.230 |
Why?
| | Attitude of Health Personnel | 1 | 2009 | 371 | 0.230 |
Why?
| | Half-Life | 1 | 2025 | 86 | 0.230 |
Why?
| | Burns | 1 | 2007 | 164 | 0.230 |
Why?
| | Physicians | 1 | 2009 | 242 | 0.230 |
Why?
| | Organ Preservation Solutions | 1 | 2025 | 5 | 0.220 |
Why?
| | Cold Ischemia | 1 | 2025 | 11 | 0.220 |
Why?
| | Aged | 8 | 2023 | 10430 | 0.220 |
Why?
| | Brain Death | 2 | 2026 | 21 | 0.210 |
Why?
| | Thermography | 2 | 2017 | 4 | 0.210 |
Why?
| | Mycoplasma hyorhinis | 1 | 2024 | 1 | 0.210 |
Why?
| | Papio | 1 | 2024 | 25 | 0.210 |
Why?
| | Mycoplasma Infections | 1 | 2024 | 7 | 0.210 |
Why?
| | Tissue Banks | 1 | 2024 | 9 | 0.210 |
Why?
| | Myocardium | 3 | 2011 | 471 | 0.200 |
Why?
| | Endocarditis, Bacterial | 1 | 2024 | 43 | 0.200 |
Why?
| | Rats, Sprague-Dawley | 3 | 2018 | 1544 | 0.200 |
Why?
| | Feasibility Studies | 1 | 2025 | 412 | 0.200 |
Why?
| | Membranes, Artificial | 3 | 2017 | 15 | 0.190 |
Why?
| | Cell Survival | 1 | 2025 | 600 | 0.190 |
Why?
| | Primates | 1 | 2023 | 21 | 0.190 |
Why?
| | Aorta, Thoracic | 1 | 2024 | 101 | 0.190 |
Why?
| | Blood Coagulation | 1 | 2023 | 65 | 0.190 |
Why?
| | Regeneration | 2 | 2021 | 83 | 0.190 |
Why?
| | Thigh | 1 | 2023 | 34 | 0.190 |
Why?
| | HLA Antigens | 1 | 2023 | 55 | 0.190 |
Why?
| | Mycophenolic Acid | 1 | 2022 | 19 | 0.190 |
Why?
| | Peritoneal Cavity | 2 | 2013 | 8 | 0.180 |
Why?
| | Severity of Illness Index | 3 | 2018 | 1049 | 0.180 |
Why?
| | Vascular Diseases | 1 | 2022 | 75 | 0.180 |
Why?
| | Rats, Inbred Lew | 2 | 2019 | 50 | 0.180 |
Why?
| | Lower Extremity | 1 | 2023 | 103 | 0.180 |
Why?
| | Transposition of Great Vessels | 1 | 2022 | 26 | 0.180 |
Why?
| | Blood Group Incompatibility | 1 | 2021 | 4 | 0.180 |
Why?
| | Pentalogy of Cantrell | 1 | 2021 | 1 | 0.170 |
Why?
| | Polytetrafluoroethylene | 1 | 2021 | 33 | 0.170 |
Why?
| | Referral and Consultation | 1 | 2024 | 299 | 0.170 |
Why?
| | Thorax | 1 | 2021 | 15 | 0.170 |
Why?
| | Diverticulum | 1 | 2021 | 21 | 0.170 |
Why?
| | Electric Impedance | 1 | 2021 | 50 | 0.170 |
Why?
| | Hepatitis, Viral, Human | 1 | 2011 | 11 | 0.170 |
Why?
| | Infant, Premature, Diseases | 1 | 2022 | 97 | 0.170 |
Why?
| | Mitral Valve | 1 | 2021 | 57 | 0.170 |
Why?
| | Age Factors | 2 | 2024 | 1136 | 0.170 |
Why?
| | Herpes Simplex | 1 | 2011 | 25 | 0.170 |
Why?
| | Metastasectomy | 1 | 2021 | 2 | 0.170 |
Why?
| | Abdomen | 2 | 2012 | 71 | 0.170 |
Why?
| | Propensity Score | 2 | 2019 | 170 | 0.170 |
Why?
| | Heart Septal Defects, Ventricular | 1 | 2021 | 46 | 0.160 |
Why?
| | Digestive System Surgical Procedures | 2 | 2012 | 32 | 0.160 |
Why?
| | Dyspnea | 2 | 2011 | 78 | 0.160 |
Why?
| | Premature Birth | 1 | 2022 | 149 | 0.160 |
Why?
| | Magnetic Resonance Imaging, Cine | 2 | 2019 | 64 | 0.160 |
Why?
| | Postoperative Period | 1 | 2020 | 169 | 0.150 |
Why?
| | Infant, Newborn, Diseases | 1 | 2020 | 56 | 0.150 |
Why?
| | Sarcoma | 1 | 2021 | 72 | 0.150 |
Why?
| | History, 21st Century | 1 | 2020 | 60 | 0.150 |
Why?
| | Heart | 2 | 2020 | 350 | 0.150 |
Why?
| | Graft vs Host Disease | 1 | 2020 | 93 | 0.150 |
Why?
| | History, 20th Century | 1 | 2020 | 97 | 0.150 |
Why?
| | Equipment Design | 1 | 2020 | 290 | 0.150 |
Why?
| | Ankle Injuries | 1 | 2019 | 10 | 0.150 |
Why?
| | Pulsatile Flow | 1 | 2019 | 18 | 0.150 |
Why?
| | Ventricular Fibrillation | 1 | 2019 | 19 | 0.150 |
Why?
| | Survival Analysis | 1 | 2021 | 659 | 0.150 |
Why?
| | Interdisciplinary Communication | 1 | 2019 | 57 | 0.140 |
Why?
| | Islets of Langerhans | 1 | 2019 | 27 | 0.140 |
Why?
| | Radiography, Thoracic | 1 | 2019 | 68 | 0.140 |
Why?
| | Health Services Needs and Demand | 1 | 2020 | 163 | 0.140 |
Why?
| | Temperature | 1 | 2019 | 165 | 0.140 |
Why?
| | Emulsions | 1 | 2018 | 25 | 0.140 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2018 | 12 | 0.140 |
Why?
| | Proctoscopes | 1 | 2018 | 1 | 0.140 |
Why?
| | Palliative Care | 1 | 2020 | 195 | 0.140 |
Why?
| | Prospective Studies | 2 | 2023 | 2412 | 0.140 |
Why?
| | Comorbidity | 1 | 2020 | 638 | 0.140 |
Why?
| | Heart, Artificial | 1 | 2018 | 3 | 0.140 |
Why?
| | Colistin | 1 | 2018 | 3 | 0.140 |
Why?
| | Anal Canal | 1 | 2018 | 27 | 0.140 |
Why?
| | Polysaccharides | 1 | 2018 | 57 | 0.140 |
Why?
| | Operative Time | 2 | 2015 | 78 | 0.130 |
Why?
| | Pneumonia, Bacterial | 1 | 2018 | 31 | 0.130 |
Why?
| | Infrared Rays | 1 | 2017 | 21 | 0.130 |
Why?
| | Cecum | 2 | 2008 | 62 | 0.130 |
Why?
| | Extracellular Matrix | 1 | 2018 | 116 | 0.130 |
Why?
| | Pseudomonas Infections | 1 | 2018 | 54 | 0.130 |
Why?
| | Heparin | 1 | 2018 | 86 | 0.130 |
Why?
| | Prosthesis Implantation | 1 | 2018 | 49 | 0.130 |
Why?
| | Monitoring, Intraoperative | 1 | 2017 | 51 | 0.130 |
Why?
| | Stem Cells | 1 | 2019 | 189 | 0.130 |
Why?
| | Pseudomonas aeruginosa | 1 | 2018 | 78 | 0.130 |
Why?
| | Cell Proliferation | 1 | 2021 | 1031 | 0.130 |
Why?
| | Optical Imaging | 1 | 2017 | 26 | 0.130 |
Why?
| | Combined Modality Therapy | 1 | 2019 | 640 | 0.130 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2017 | 29 | 0.130 |
Why?
| | Aged, 80 and over | 3 | 2020 | 3495 | 0.130 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 302 | 0.130 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 38 | 0.120 |
Why?
| | Endocarditis, Non-Infective | 1 | 2016 | 2 | 0.120 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2019 | 224 | 0.120 |
Why?
| | Thoracoplasty | 1 | 2016 | 3 | 0.120 |
Why?
| | Funnel Chest | 1 | 2016 | 11 | 0.120 |
Why?
| | Ligation | 2 | 2013 | 63 | 0.120 |
Why?
| | Prosthesis-Related Infections | 1 | 2017 | 109 | 0.110 |
Why?
| | Potassium Compounds | 1 | 2015 | 2 | 0.110 |
Why?
| | Antigens, CD | 1 | 2016 | 217 | 0.110 |
Why?
| | Lung Diseases | 1 | 2016 | 84 | 0.110 |
Why?
| | Wounds and Injuries | 2 | 2008 | 301 | 0.110 |
Why?
| | Epithelium | 2 | 2012 | 64 | 0.110 |
Why?
| | Lidocaine | 1 | 2015 | 46 | 0.110 |
Why?
| | Lung Neoplasms | 1 | 2021 | 645 | 0.110 |
Why?
| | Risk Assessment | 1 | 2019 | 1368 | 0.110 |
Why?
| | Curriculum | 1 | 2017 | 409 | 0.100 |
Why?
| | Myocardial Contraction | 2 | 2011 | 109 | 0.100 |
Why?
| | Risk Factors | 2 | 2020 | 4018 | 0.100 |
Why?
| | Free Tissue Flaps | 1 | 2015 | 63 | 0.100 |
Why?
| | Survival Rate | 3 | 2021 | 949 | 0.100 |
Why?
| | Macrophages | 1 | 2016 | 380 | 0.100 |
Why?
| | Germany | 2 | 2010 | 26 | 0.100 |
Why?
| | Esophagectomy | 1 | 2014 | 38 | 0.100 |
Why?
| | Cell Adhesion | 2 | 2016 | 163 | 0.100 |
Why?
| | Bandages | 1 | 2013 | 28 | 0.100 |
Why?
| | Clinical Competence | 1 | 2016 | 406 | 0.100 |
Why?
| | Laparotomy | 1 | 2013 | 37 | 0.100 |
Why?
| | Heart Diseases | 1 | 2015 | 221 | 0.090 |
Why?
| | Gastric Bypass | 1 | 2012 | 21 | 0.090 |
Why?
| | Injections, Intraperitoneal | 1 | 2012 | 55 | 0.090 |
Why?
| | Pyruvate Dehydrogenase (Lipoamide) | 1 | 2012 | 1 | 0.090 |
Why?
| | Esophageal Neoplasms | 1 | 2014 | 113 | 0.090 |
Why?
| | Histocytochemistry | 1 | 2012 | 44 | 0.090 |
Why?
| | Succinate Dehydrogenase | 1 | 2012 | 22 | 0.090 |
Why?
| | Intraoperative Care | 1 | 2012 | 51 | 0.090 |
Why?
| | Preoperative Care | 1 | 2013 | 173 | 0.090 |
Why?
| | Cystadenoma, Serous | 1 | 2012 | 5 | 0.090 |
Why?
| | Foreign-Body Reaction | 3 | 2017 | 9 | 0.090 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 198 | 0.090 |
Why?
| | Pancreatic Ducts | 1 | 2012 | 13 | 0.090 |
Why?
| | Pilot Projects | 2 | 2011 | 727 | 0.090 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 62 | 0.090 |
Why?
| | Isoproterenol | 1 | 2011 | 55 | 0.090 |
Why?
| | Diagnosis, Differential | 3 | 2012 | 1038 | 0.090 |
Why?
| | Second-Look Surgery | 1 | 2011 | 4 | 0.090 |
Why?
| | Random Allocation | 1 | 2012 | 284 | 0.090 |
Why?
| | Acidosis | 1 | 2011 | 37 | 0.090 |
Why?
| | Ascites | 1 | 2011 | 31 | 0.090 |
Why?
| | Biological Science Disciplines | 1 | 2011 | 2 | 0.090 |
Why?
| | Endocardium | 1 | 2011 | 4 | 0.080 |
Why?
| | Lasers, Excimer | 1 | 2011 | 3 | 0.080 |
Why?
| | Cardiotonic Agents | 1 | 2011 | 70 | 0.080 |
Why?
| | Phrenic Nerve | 1 | 2011 | 6 | 0.080 |
Why?
| | Heart Injuries | 1 | 2011 | 16 | 0.080 |
Why?
| | Mammary Arteries | 1 | 2010 | 10 | 0.080 |
Why?
| | Alopecia | 1 | 2011 | 38 | 0.080 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2010 | 33 | 0.080 |
Why?
| | Tinnitus | 1 | 2011 | 64 | 0.080 |
Why?
| | Infertility | 1 | 2010 | 17 | 0.080 |
Why?
| | Scoliosis | 1 | 2011 | 63 | 0.080 |
Why?
| | Laser Therapy | 1 | 2011 | 75 | 0.080 |
Why?
| | Fibrosis | 3 | 2017 | 198 | 0.080 |
Why?
| | Leiomyoma | 1 | 2010 | 21 | 0.080 |
Why?
| | Disclosure | 1 | 2010 | 40 | 0.080 |
Why?
| | Adenocarcinoma | 1 | 2014 | 405 | 0.080 |
Why?
| | Intestinal Obstruction | 1 | 2010 | 38 | 0.080 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2010 | 189 | 0.080 |
Why?
| | Fallopian Tubes | 1 | 2009 | 22 | 0.080 |
Why?
| | Wounds, Nonpenetrating | 1 | 2011 | 86 | 0.080 |
Why?
| | Chi-Square Distribution | 1 | 2010 | 291 | 0.080 |
Why?
| | Uterine Neoplasms | 1 | 2010 | 57 | 0.080 |
Why?
| | Electrosurgery | 1 | 2009 | 10 | 0.080 |
Why?
| | Myocardial Ischemia | 1 | 2010 | 129 | 0.070 |
Why?
| | Pancreatic Neoplasms | 1 | 2012 | 219 | 0.070 |
Why?
| | Cardiomyopathies | 1 | 2010 | 120 | 0.070 |
Why?
| | Triplets | 1 | 2009 | 1 | 0.070 |
Why?
| | Vagina | 1 | 2009 | 45 | 0.070 |
Why?
| | Serous Membrane | 1 | 2008 | 3 | 0.070 |
Why?
| | Electrocardiography | 1 | 2010 | 272 | 0.070 |
Why?
| | Confidentiality | 1 | 2009 | 44 | 0.070 |
Why?
| | Efficiency, Organizational | 1 | 2009 | 42 | 0.070 |
Why?
| | Recurrence | 1 | 2010 | 694 | 0.070 |
Why?
| | Abortion, Therapeutic | 1 | 2008 | 3 | 0.070 |
Why?
| | Hot Temperature | 1 | 2009 | 202 | 0.070 |
Why?
| | Sus scrofa | 2 | 2024 | 38 | 0.070 |
Why?
| | Toxicity Tests | 1 | 2008 | 57 | 0.070 |
Why?
| | Atrial Fibrillation | 1 | 2011 | 196 | 0.070 |
Why?
| | Cardiac Catheterization | 1 | 2010 | 229 | 0.070 |
Why?
| | Spinal Cord Compression | 1 | 2008 | 13 | 0.070 |
Why?
| | Cervix Uteri | 1 | 2008 | 43 | 0.070 |
Why?
| | Takayasu Arteritis | 1 | 2008 | 1 | 0.070 |
Why?
| | Autopsy | 1 | 2008 | 46 | 0.070 |
Why?
| | Gynecologic Surgical Procedures | 1 | 2008 | 29 | 0.070 |
Why?
| | Veins | 1 | 2008 | 74 | 0.070 |
Why?
| | Evaluation Studies as Topic | 1 | 2008 | 101 | 0.070 |
Why?
| | Internet | 1 | 2010 | 265 | 0.070 |
Why?
| | Arteries | 1 | 2008 | 93 | 0.070 |
Why?
| | Delivery, Obstetric | 1 | 2009 | 109 | 0.070 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2008 | 31 | 0.070 |
Why?
| | Attitude to Health | 1 | 2009 | 193 | 0.060 |
Why?
| | Costs and Cost Analysis | 1 | 2007 | 93 | 0.060 |
Why?
| | Ultrasonography | 1 | 2009 | 426 | 0.060 |
Why?
| | Rabbits | 1 | 2008 | 372 | 0.060 |
Why?
| | Uterus | 1 | 2007 | 81 | 0.060 |
Why?
| | Coronary Artery Disease | 1 | 2010 | 324 | 0.060 |
Why?
| | Sheep | 3 | 2011 | 99 | 0.060 |
Why?
| | Cells, Cultured | 1 | 2008 | 1569 | 0.050 |
Why?
| | Swine Diseases | 1 | 2024 | 7 | 0.050 |
Why?
| | Immunocompromised Host | 1 | 2024 | 124 | 0.050 |
Why?
| | Prevalence | 2 | 2020 | 1034 | 0.050 |
Why?
| | Inflammation | 2 | 2017 | 653 | 0.050 |
Why?
| | Leg | 1 | 2022 | 123 | 0.050 |
Why?
| | Infant, Low Birth Weight | 1 | 2022 | 77 | 0.040 |
Why?
| | ABO Blood-Group System | 1 | 2021 | 16 | 0.040 |
Why?
| | Skin Diseases, Viral | 1 | 2011 | 4 | 0.040 |
Why?
| | Simplexvirus | 1 | 2011 | 17 | 0.040 |
Why?
| | International Normalized Ratio | 1 | 2011 | 29 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2021 | 121 | 0.040 |
Why?
| | Heart Rate | 1 | 2022 | 313 | 0.040 |
Why?
| | Bilirubin | 1 | 2011 | 43 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 1 | 2008 | 1587 | 0.040 |
Why?
| | Colorado | 1 | 2020 | 24 | 0.040 |
Why?
| | DNA, Viral | 1 | 2011 | 136 | 0.040 |
Why?
| | Gestational Age | 1 | 2022 | 394 | 0.040 |
Why?
| | Health Policy | 1 | 2021 | 165 | 0.040 |
Why?
| | Thrombocytopenia | 1 | 2011 | 89 | 0.040 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2011 | 158 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 452 | 0.040 |
Why?
| | Splints | 1 | 2019 | 6 | 0.040 |
Why?
| | Casts, Surgical | 1 | 2019 | 11 | 0.040 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2011 | 150 | 0.040 |
Why?
| | Anesthesia, Local | 1 | 2019 | 18 | 0.040 |
Why?
| | Endocrine System | 1 | 2019 | 16 | 0.040 |
Why?
| | Liver Transplantation | 1 | 2011 | 174 | 0.040 |
Why?
| | Azides | 1 | 2018 | 9 | 0.040 |
Why?
| | Click Chemistry | 1 | 2018 | 4 | 0.040 |
Why?
| | Chronic Disease | 2 | 2010 | 581 | 0.030 |
Why?
| | Staining and Labeling | 1 | 2018 | 94 | 0.030 |
Why?
| | Cardioplegic Solutions | 1 | 2017 | 3 | 0.030 |
Why?
| | Computer Systems | 1 | 2017 | 17 | 0.030 |
Why?
| | Enterococcus | 1 | 2017 | 9 | 0.030 |
Why?
| | Antiphospholipid Syndrome | 1 | 2016 | 8 | 0.030 |
Why?
| | Epithelial Cells | 1 | 2018 | 218 | 0.030 |
Why?
| | Pneumonectomy | 1 | 2016 | 29 | 0.030 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2016 | 67 | 0.030 |
Why?
| | Area Under Curve | 1 | 2016 | 185 | 0.030 |
Why?
| | Specialties, Surgical | 1 | 2016 | 33 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2018 | 289 | 0.030 |
Why?
| | Creatine Kinase, MB Form | 1 | 2015 | 10 | 0.030 |
Why?
| | Angiography | 1 | 2016 | 114 | 0.030 |
Why?
| | Academic Medical Centers | 1 | 2016 | 153 | 0.030 |
Why?
| | Wound Healing | 1 | 2016 | 226 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2016 | 933 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2015 | 598 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 1925 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2012 | 43 | 0.020 |
Why?
| | Logistic Models | 1 | 2015 | 947 | 0.020 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 1 | 2012 | 8 | 0.020 |
Why?
| | Pancreaticoduodenectomy | 1 | 2012 | 13 | 0.020 |
Why?
| | Cohort Studies | 1 | 2016 | 1557 | 0.020 |
Why?
| | Sheep, Domestic | 1 | 2011 | 12 | 0.020 |
Why?
| | Length of Stay | 1 | 2015 | 684 | 0.020 |
Why?
| | Databases, Factual | 1 | 2015 | 742 | 0.020 |
Why?
| | Rupture | 1 | 2011 | 24 | 0.020 |
Why?
| | Models, Biological | 1 | 2014 | 737 | 0.020 |
Why?
| | Injections, Intra-Arterial | 1 | 2010 | 14 | 0.020 |
Why?
| | Polystyrenes | 1 | 2010 | 5 | 0.020 |
Why?
| | Microspheres | 1 | 2010 | 19 | 0.020 |
Why?
| | Salaries and Fringe Benefits | 1 | 2010 | 15 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 38 | 0.020 |
Why?
| | Job Satisfaction | 1 | 2010 | 35 | 0.020 |
Why?
| | Pulmonary Veins | 1 | 2011 | 41 | 0.020 |
Why?
| | Certification | 1 | 2010 | 52 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2010 | 267 | 0.020 |
Why?
| | Mitral Valve Insufficiency | 1 | 2010 | 56 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2010 | 120 | 0.020 |
Why?
| | Stroke Volume | 1 | 2010 | 150 | 0.020 |
Why?
| | Hysterectomy | 1 | 2009 | 91 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 579 | 0.020 |
Why?
| | Diagnostic Imaging | 1 | 2011 | 176 | 0.020 |
Why?
| | Blotting, Western | 1 | 2010 | 587 | 0.020 |
Why?
| | Ventricular Function, Left | 1 | 2010 | 178 | 0.020 |
Why?
| | Phosphorylation | 1 | 2010 | 533 | 0.020 |
Why?
| | Up-Regulation | 1 | 2010 | 456 | 0.020 |
Why?
| | Pregnancy Tests | 1 | 2008 | 2 | 0.020 |
Why?
| | Uterine Hemorrhage | 1 | 2008 | 7 | 0.020 |
Why?
| | Chorionic Gonadotropin | 1 | 2008 | 19 | 0.020 |
Why?
| | Heart Ventricles | 1 | 2010 | 260 | 0.020 |
Why?
| | Sex Factors | 1 | 2010 | 747 | 0.020 |
Why?
| | Treatment Failure | 1 | 2008 | 119 | 0.020 |
Why?
| | Cesarean Section | 1 | 2009 | 158 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2010 | 1221 | 0.020 |
Why?
| | Pregnancy Outcome | 1 | 2008 | 231 | 0.010 |
Why?
| | Pregnancy Complications | 1 | 2009 | 406 | 0.010 |
Why?
|
|
Rajab's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Same Department
People who are also in this person's primary department.
|